Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-28
1987-10-27
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514806, 530317, 530318, 530311, A61K 3702, C07K 512, C07K 726
Patent
active
047030348
ABSTRACT:
There is disclosed a series of novel cyclic tetrapeptides related to somatostatin. The compounds have surprisingly been found to have the activity of increasing blood glucose when administered. The compounds are prepared using the solid phase or mixed anhydride synthesis methods and compositions and methods utilizing the novel compounds are also disclosed.
REFERENCES:
patent: 4310518 (1982-01-01), Freidinger et al.
Freidinger Roger
Lyle Terry A.
Nutt Ruth F.
Saperstein Richard
Merck & Co. , Inc.
Phillips Delbert R.
Rose David L.
Sudol, Jr. Michael C.
LandOfFree
Novel cyclic tetrapeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cyclic tetrapeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cyclic tetrapeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1272316